Alignment Healthcare Inc [ALHC] stock is trading at $20.42, up 0.05%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALHC shares have gain 5.48% over the last week, with a monthly amount glided 25.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alignment Healthcare Inc [NASDAQ: ALHC] stock has seen the most recent analyst activity on November 24, 2025, when JP Morgan upgraded its rating to a Overweight but kept the price target unchanged to $20 for it. Previously, Goldman started tracking the stock with Buy rating on October 14, 2025, and set its price target to $21. On August 25, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $21 on the stock. Barclays upgraded its rating to a Equal Weight but stick to its price target of $13 on July 31, 2025. Stephens upgraded its rating to a Overweight and raised its price target to $17 on December 03, 2024. In a note dated May 30, 2024, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $7.75 to $11.
Alignment Healthcare Inc [ALHC] stock has fluctuated between $10.18 and $21.06 over the past year. Currently, Wall Street analysts expect the stock to reach $19.75 within the next 12 months. Alignment Healthcare Inc [NASDAQ: ALHC] shares were valued at $20.42 at the most recent close of the market. An investor can expect a potential drop of -3.28% based on the average ALHC price forecast.
Analyzing the ALHC fundamentals
Alignment Healthcare Inc [NASDAQ:ALHC] reported sales of 3.64B for the trailing twelve months, which represents a growth of 43.51%. Gross Profit Margin for this corporation currently stands at 0.09% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.16 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 20.19 points at the first support level, and at 19.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.64, and for the 2nd resistance point, it is at 20.86.
Ratios To Look Out For
For context, Alignment Healthcare Inc’s Current Ratio is 1.61. Considering the valuation of this stock, the price to sales ratio is 1.12, the price to book ratio is 25.23.
Transactions by insiders
Recent insider trading involved Maroney Dawn Christine, President, that happened on Dec 15 ’25 when 0.11 million shares were sold. President, Maroney Dawn Christine completed a deal on Dec 12 ’25 to sell 16681.0 shares. Meanwhile, Officer DAWN MARONEY bought 0.21 million shares on Dec 15 ’25.
